Describes nursing-integrated biomarker surveillance strategies to detect immune-related adverse events during immune checkpoint inhibitor therapy and how to operationalize them.
Key Takeaways
- Routine labs like CBC, metabolic panels, thyroid tests, and troponin are practical for serial irAE surveillance
- Dynamic biomarker trends are generally more informative than single isolated values for early irAE detection
- Prospective studies are needed to validate multimarker panels and nursing-led pathways to reduce severe irAEs